| INTRODUCTION
One of the ever-present and feared complications of type 1 diabetes (T1D) is severe hypoglycemia (SH), which can lead to seizure and loss of consciousness. Fear of hypoglycemia is especially common in families of young children with T1D due to the challenges parents face in striving to maintain optimal glycemic control during this unique developmental stage. 1 In addition to unpredictable eating habits, irregular bouts of physical activity, and labile behavior, young children have limited ability to communicate symptoms of low blood glucose concentrations, and parents often cannot recognize that their children's glucose levels are falling. 2 Even in older children, parental detection of hypoglycemia is limited. 3 Parental fear of hypoglycemia may interfere with achievement of glycemic treatment targets, 4 as some families may aim for higher blood glucose levels for their children in order to avoid lows, due to concerns about acute and chronic neurologic effects of hypoglycemia.
Among parents with older children (mean ages 8-10 years) with T1D, greater parental worry has been associated with poorer glycemic control. [5] [6] [7] In contrast, small single-center studies of parents with younger children (ages 2-8 years) have not identified a significant relationship, 1, 8 and their smaller size limited generalizability to the broader national population of young children with T1D. A clearer understanding of the specific fears experienced by parents of young children related to hypoglycemia, and of the relationship between these fears and glycemic outcomes, is essential before diabetes clinicians and researchers can develop intervention strategies targeting parental fear of hypoglycemia.
Characterizing fear of hypoglycemia among parents of young children also is an important step towards achieving the more strin- 
| Hypoglycemia Fear Survey for use by parents (HFS-P)
The original HFS 20 was developed by Cox et al to assess both behaviors and worries related to hypoglycemia in adults with T1D. This tool was modified for use by parents/guardians (HFS-P) of children with T1D, 7 and has been shown to be a reliable and valid tool.
21,22
The questionnaire provided to parents of youth in this analysis included only the worry scale, in which the term "reaction" was modified to "low" and the item on "child losing control" was expanded to
"child losing control due to low blood sugar". Parents were asked to rate their agreement with 15 statements regarding worries related to hypoglycemia using a 0 (never) to 4 (almost always) Likert scale, which was scored for each participant as the mean of all non-missing responses multiplied by 25, for a maximum total score out of 100.
Higher worry scores represent greater fear of hypoglycemia.
| Statistical analyses
The mean worry score was calculated overall and according to various demographic and clinical characteristics. Associations between mean HFS-P worry score and each demographic and clinical characteristic were assessed using T-tests or the Wilcoxon Rank-Sum procedure (or Kruskal Wallis if >2 levels) as appropriate. Adjusted linear regression models were performed to assess associations between HFS-P worry score and each glycemic outcome: HbA1c, occurrence of SH, and occurrence of DKA, separately. The demographic and clinical characteristics used to adjust the models were determined by a stepwise selection procedure, where any factor with a P-value <0.1 remained in the final adjusted model. The associations between worry score and glycemic outcomes were further stratified by insulin pump and CGM use.
Parental ratings for each individual item on the HFS-P worry scale were tabulated overall and according to age group (≤3 and 4-6 years). Additionally, associations of the most frequently reported worry with diabetes management and glycemic outcomes were assessed using chi-square tests. Data analyses were performed using SAS version 9.4 (2011 SAS Institute Inc., Cary, North Carolina). All P-values were two-sided. Due to multiple comparisons only P-values <.01 were considered statistically significant.
3 | RESULTS
| Participant characteristics
Parents/guardians of 549 children with T1D under age 7 participated in the survey. The mean age of the child participants was 5.2 AE 1.2 years (19% <3 years) and mean duration of diabetes was 2.4 AE 1.0 years (range 1-6 years). Mean HbA1c was 8.2% AE 1.1% (66 AE 12 mmol/mol). Approximately one-third (32%) of the children were current CGM users and more than half (58%) were using insulin pumps.
Additional cohort characteristics are shown in Table 1 .
| Mean worry score
The mean HFS-P worry score was 36.1 AE 23.1. Parents of children ≤3 years did not report greater worry than parents of children aged 4-6 years (P = .47, Table 1 ). Parental worry was slightly higher for children using an insulin pump vs injections, though this difference was not significant (P = 0.06, Table 1 ). No difference in parental worry was observed for children using CGM vs no CGM (P = 0.86, Table 1 ). The mean worry score among parents who reported performing blood glucose monitoring ≥6 times per day was higher than those who reported checking blood glucose <6 times per day (37.7 AE 23.2 vs 31.8 AE 22.3; P = .004).
Worry score and HbA1c were not significantly associated (unadjusted P = .79, P = .89 after adjusting for gender of the child and frequency of blood glucose monitoring; Table 1 ). Significant associations of the worry scale with HbA1c also were not observed in separate analyses of pump users compared with non-users and of CGM users compared with non-users.
The mean HFS-P worry score was not significantly greater among parents/guardians of children that had at least one SH event (7% of sample) in the past three months compared with those who had no SH events in the past 3 months (adjusted P = 0.95; Table 1 ).
Similarly, no association was found between worry score and occurrence of a DKA event (5% had ≥1 event in the past 3 months, adjusted P = .71; Table 1 ). Stratifying these analyses by pump use and CGM use did not demonstrate any significant relationship between occurrences of SH and DKA and total worry score.
| Frequency of reported worries
Parents reported most frequently worrying about their child having a low blood glucose while asleep and their child not recognizing a low glucose, with 54% and 47% respectively reporting feeling worried "often" or "almost always" about these experiences ( Table 2 ). The least frequently reported worries involved the child embarrassing themselves, friends, or family in social situations and appearing "stupid" or clumsy (Table 2 ).
Since parents most frequently worried about hypoglycemia during sleep, this most common worry was further evaluated as shown in Figure 1 . There was not a statistically significant difference in frequency of worry about the child having a low while asleep among parents of children ≤3 years of age compared with parents of children age 4 to 6 (P = .09, Figure 1 ). Parents whose children used an insulin pump worried significantly more often about their child having a low while asleep than parents whose children did not use an insulin pump (61% of parents of pump users vs 45% of parents of non-users; P < .001, Figure 1 ). There were trends towards higher parental worry about lows during sleep among CGM users compared with non-users (62% of parents of CGM users vs 51% of parents of non-users; P = .02) and among parents whose children had no SH event in the past 3 months compared with those with at least one event (56% with no event vs 34% with event; P = 0.01, Figure 1) . No difference in frequency of worry about lows during sleep was seen among parents of children with HbA1c below the target versus above the target range, or for those with children who had no DKA event versus at least one DKA event in the past 3 months.
| DISCUSSION
Parents of young children with T1D in this large sample reported that they most frequently experience fear of hypoglycemia in contexts which may make it difficult for the parent to detect hypoglycemiaduring sleep and when the child does not recognize he or she is having a low. Maintaining higher glucose levels to avoid hypoglycemia is a strategy reportedly used by some families in clinical practice to mitigate hypoglycemia fear; however our results indicate that fear of hypoglycemia persists regardless of glycemic control.
There are a limited number of studies evaluating fear of hypoglycemia in parents of young children with T1D. Patton et al studied parents of 81 children aged 2 to 8 years diagnosed with T1D and found that fear of hypoglycemia was common in parents, and greatest in mothers. Similar to our findings, there was no relationship between HbA1c and hypoglycemia fear. 1, 8 While fear of hypoglycemia has been reported to be associated with worse glycemic control in older children and adolescents, [5] [6] [7] unique characteristics of young children and their care may contribute to the lack of association, including the intense monitoring practiced by many parents. Thus, while main goals in young children with T1D are improving HbA1c and reducing glycemic variability, parental fear of hypoglycemia does not seem to be a primary barrier to meeting these goals.
Despite this finding, addressing fear of hypoglycemia is important in the youngest age group, especially in relation to parental quality of life. It is not surprising that the most frequent hypoglycemia worry in this young age group is related to hypoglycemia during sleep. 8 Parents have reported that caring for a young child with T1D demands "constant vigilance". 23 The overnight time period presents challenges to this concept as constant vigilance is more difficult when children are asleep, and attempts to achieve it have detrimental effects on parents' sleep quality 24 and, hence, on quality of life, which may lead parents to compensate by targeting a higher blood glucose overnight.
Advancements in diabetes technology may help address some of the difficulties managing young children's diabetes during sleep. Preschool children require higher basal rates of insulin in the evening and lower doses after midnight, which can be challenging to achieve using insulin injections, 25 while insulin pumps can provide small varying doses of basal insulin overnight and are associated with a reduced risk of SH in children. 26 Insulin pump use may also contribute to the marked decrease in SH events in adolescents, 27, 28 and SH events are P-value from the adjusted model. All models were adjusted for gender and frequency of self-monitoring blood glucose per day.
b Occurrence of at least one severe hypoglycemia (SH) event in the past 3 months resulting in seizure or loss of consciousness, and occurrence of at least one diabetic ketoacidosis (DKA) event in the past 3 months.
no longer associated with achieving HbA1c targets. 28 Additionally, CGM systems provide real-time as well as retrospective information about glucose levels, alerts for low glucose levels, and integrated, sensor-augmented pump systems can automatically suspend basal rates if sensor glucose levels reach a pre-determined low threshold.
Use of these technologies has the potential to alleviate some parental burden such as worry of missing nocturnal hypoglycemia and waking to perform blood glucose checks, as well as provide data for dose adjustments to optimize overnight control. Indeed, CGM detects hypoglycemia more effectively than frequent blood glucose checks in young children. 29 Despite the presumed benefits of insulin pumps and CGM, worries about hypoglycemia during sleep were more frequent in parents of children using insulin pumps and tended to be higher in those Not having food, fruit, or juice 22
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FIGURE 1 Endorsed worry about child having hypoglycemia while asleep. Solid black bar represents yes. Sold white bar represents no young populations with T1D, given the relatively high average parental educational attainment and income, and relatively low racial/ethnic diversity. Gender of the survey respondent (parent) would have provided additional insight into interpreting the score, as greater hypoglycemia fear scores have been reported in mothers compared with fathers. 1, 6 It is noteworthy that 32% of families of young children in this study were using CGM, which is 2-3-fold higher than current CGM use in adolescents and young adults enrolled in the T1D Exchange registry. 30 This sharp increase in CGM utilization likely reflects an increase in parental and clinician perceptions of the benefits and increased ease of use of these devices, alone and in combination with insulin pump therapy. Thus, this may be an optimal time to assess how more widespread use of advances in diabetes technology impact fear of hypoglycemia in parents of young children with T1D.
